Omni Bio Pharmaceutical, Inc. announced that on June 23, 2015, John Riccardi was appointed to fill a vacant seat on the company's board of directors. All other members of the company's board of directors Michael Kamarck, Albert Kramer, Sandra Wrobel, Michael Wort and Bruce Schneider resigned effective June 24, 2015. Mr. Riccardi will serve on behalf of the company to wind up any remaining administrative matters.

On June 16, 2015, Charles Dinarello resigned as the company's Chief Science Officer. On June 24, 2015, Bruce Schneider resigned from the as Chief Executive Officer and John Riccardi resigned as Chief Financial Officer.